# @mynyit on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/Bf_oZuVlqch
- **Gondola URL:** https://gondola.cc/posts/19751183-mynyit-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/thumbnails/3b707ad1b0.jpg
- **Posted:** 2018-03-06T19:54:39.000+00:00
- **Account Owner:** New York Tech (@mynyit) — https://gondola.cc/mynyit

## Caption

Julia Schneider, a second-year student at NYIT College of Osteopathic Medicine (NYITCOM), is wasting no time pursuing her dream to become a neurosurgeon. “I always knew that I wanted to wake up in the morning or in the middle of the night or at any point in the day and save a person’s life,” she says. “I want to be the kind of neurosurgeon that doesn’t just tell my future patients (who may come in with a headache and clean CT or MRI scan) to go see a neurologist; I also want to give them options. My goal is to strengthen the doctor-patient relationship because that will enhance patient care and outcomes.”
Between taking classes and studying for boards, Schneider also finds time to research the complexities of the nervous system. Thanks to her extensive exploration of the subject, she was named the 2018 National Student Researcher of the Year by the Council of Osteopathic Student Government Presidents. “I am delighted to have their respect and recognition,” she says. Schneider has conducted clinical, basic science, and translational research. This three-dimensional approach, she explains, sets her apart in more ways than one. “I am able to think of different approaches at the [research] bench, which will help improve my bedside manner,” she says.
Since 2016, Schneider has been working at both The Feinstein Institute for Medical Research and Lenox Hill Neurosurgery as a research scholar. She and her mentor John Boockvar, M.D., have been working on disrupting the blood brain barrier (BBB)—a filtering mechanism of the capillaries that carry blood to the brain and spinal cord tissue, blocking the delivery of certain substances—while delivering chemotherapy drugs through the artery to deliver the drugs directly to the tumor.
She is also working on developing a new clinical trial to bypass the BBB. “The BBB has been a major impediment in getting chemotherapy drugs to the brain and directly to the tumor, so this is an important obstacle to address,” she explains.
#studentprofile #beartales

## Stats

- **Views:** 0
- **Likes:** 55
- **Shares:** 0
- **Comments:** 1

## Tags

beartales, studentprofile

---
Copyright (c) Gondola